Biopharma Hedge Funds Cool After Breakout Year
Strong 2025 gains give way to uneven results as stock swings and clinical setbacks weigh on performance.
Recent Articles
Strong 2025 gains give way to uneven results as stock swings and clinical setbacks weigh on performance.